Pharmacotherapy for chronic obesity management: a look into the future
-
Abdel-Malek M, Yang L, Miras AD.
Pharmacotherapy for chronic obesity management: a look into the future Intern Emerg Med
Publication Category: Medications
Balancing the scales: the interplay of diet, exercise, GLP-1 receptor agonists, and obesity in shaping male reproductive health
-
Ammar OF, Sharma K, Liperis G, Fraire-Zamora JJ, Serdarogullari M, Ali ZE, Ramasamy R, Laurentino S, Watkins A, Mincheva M.
Balancing the scales: the interplay of diet, exercise, GLP-1 receptor agonists, and obesity in shaping male reproductive health Hum Reprod
Tirzepatide 10 and 15 mg compared with semaglutide 2.4 mg for the treatment of obesity: An indirect treatment comparison
-
le Roux CW, Hankosky ER, Wang D, Malik R, Yu M, Hickey A, Kan H, Bunck MC, Stefanski A, Garcia-Perez LE, Wharton S.
Tirzepatide 10 and 15 mg compared with semaglutide 2.4 mg for the treatment of obesity: An indirect treatment comparison Diabetes Obes Metab
Weight loss and long-term weight loss maintenance with naltrexone ER/bupropion ER combination therapy
-
C. Le Roux; M. Burrows; J. Blavignac; F. Camacho; E. Gould; M. Barakat
Weight loss and long-term weight loss maintenance with naltrexone ER/bupropion ER combination therapy Obesity reviews
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
-
D. C. W. Lau; L. Erichsen; A. M. Francisco; A. Satylganova; C. W. le Roux; B. McGowan; S. D. Pedersen; K. H. Pietilainen; D. Rubino; R. L. Batterham
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial Lancet
Intraoperative Monitoring of the Obese Patient Undergoing Surgery: A Narrative Review
-
A. P. Haren; S. Nair; M. C. Pace; P. Sansone
Intraoperative Monitoring of the Obese Patient Undergoing Surgery: A Narrative Review Adv Ther
Effects of a Milk-Based Meal Replacement Program on Weight and Metabolic Characteristics in Adults with Severe Obesity
- M. F. Rafey; C. F. Murphy; R. Abdalgwad; K. Kilkelly; H. Griffin; N. Beatty; P. M. O'Shea; C. Collins; R. McGrath; M. Hynes; C. Davenport; M. O'Donnell; F. M. Finucane Effects of a Milk-Based Meal Replacement Program on Weight and Metabolic Characteristics in Adults with Severe Obesity Diabetes, metabolic syndrome and obesity : targets and therapy
Weight loss outcomes with semaglutide 2.4 mg in moderate or severe obesity in step 1 and 2
- C. Le Roux; A. Aminian; R. Batterham; D. Hesse; C. Jensen; B. McGowan; A. Pakseresht; G. Rigas Sydney; F. Rubino; S. Taheri; et al. Weight loss outcomes with semaglutide 2.4 mg in moderate or severe obesity in step 1 and 2 Obesity (Silver Spring, Md.)
Cross-sectional study of the association between skin tags and vascular risk factors in a bariatric clinic-based cohort of Irish adults with morbid obesity
- C. E. H. Fang; C. Crowe; A. Murphy; M. O'Donnell; F. M. Finucane Cross-sectional study of the association between skin tags and vascular risk factors in a bariatric clinic-based cohort of Irish adults with morbid obesity BMC Res Notes